pH-responsive glycodendrimer as a new active targeting agent for doxorubicin delivery

Int J Biol Macromol. 2022 Nov 30:221:508-522. doi: 10.1016/j.ijbiomac.2022.09.037. Epub 2022 Sep 9.

Abstract

The present study synthesized a new kind of pH-responsive active targeting glycodendrimer (ATGD) for doxorubicin delivery to cancerous cells. First, the glycodendrimer was synthesized based on the cultivation of chitosan dendrons on amine-functionalized, silica-grafted cellulose nanocrystals. Afterward, glycodendrimer was conjugated with folic acid to provide a folate receptor-targeting agent. The response surface method was employed to obtain the optimum conditions for the preparation of doxorubicin-loaded ATGD. The effect of doxorubicin/ATGD ratio, temperature, and pH on doxorubicin loading capacity was evaluated, and high loading capacity was achieved under optimized conditions. After determining doxorubicin release pattern at acidic and physiological pH, ATGD cytotoxicity was surveyed by MTT assay. Based on the results, the loading behavior of doxorubicin onto ATGD was in good agreement with monolayer-physisorption, and drug release was Fickian diffusion-controlled. ATGD could release the doxorubicin much more at acidic pH than physiological pH, corresponding to pH-responsive release behavior. Results of MTT assay confirmed the cytotoxicity of doxorubicin-loaded ATGD in cancer cells, while ATGD (without drug) was biocompatible with no tangible toxicity. These results suggested that ATGD has the potential for the treatment of cancer.

Keywords: Cellulose nanocrystals; Chitosan; Doxorubicin; Glycodendrimer; Targeted drug delivery.

MeSH terms

  • Chitosan* / chemistry
  • Doxorubicin / chemistry
  • Doxorubicin / pharmacology
  • Drug Carriers / chemistry
  • Drug Delivery Systems
  • Drug Liberation
  • Hydrogen-Ion Concentration
  • Nanoparticles* / chemistry

Substances

  • Doxorubicin
  • Chitosan
  • Drug Carriers